Daniel S. Zaharko
- Molecular Biology top 10%
- Oncology top 5%
- Pharmacology top 1%
- Public Health, Environmental and Occupational Health top 5%
- Biomaterials top 5%
- Co-authors
- Robert L. DedrickKenneth B. BischoffJohn N. WeinsteinRichard L. MaginJames LongstrethVincent T. OliverioLyle V. BeckMilton B. Yatvin
- Topics
- Acute Lymphoblastic Leukemia research (18 papers)Chronic Myeloid Leukemia Treatments (11 papers)Cancer therapeutics and mechanisms (8 papers)
- Cited by
- PharmacologyBiomaterialsOncology
- Partner nations
- United StatesMalaysiaItaly
In The Last Decade
Daniel S. Zaharko
63 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.0k
- Oncology 552
- Pharmacology 367
- Public Health, Environmental and Occupational Health 332
- Biomaterials 317
Countries citing papers authored by Daniel S. Zaharko
This map shows the geographic impact of Daniel S. Zaharko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Zaharko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Zaharko more than expected).
Fields of papers citing papers by Daniel S. Zaharko
This network shows the impact of papers produced by Daniel S. Zaharko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Zaharko. The network helps show where Daniel S. Zaharko may publish in the future.
Co-authorship network of co-authors of Daniel S. Zaharko
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Zaharko. A scholar is included among the top collaborators of Daniel S. Zaharko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Zaharko. Daniel S. Zaharko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice. | 1 |
| 3 | 9 | |
| 4 | 14 | |
| 5 | 18 | |
| 6 | Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. | 53 |
| 7 | 7 | |
| 8 | DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells. | 35 |
| 9 | 27 | |
| 10 | 4 | |
| 11 | Pharmacokinetic studies during phase I trials of high-dose thymidine infusions. | 39 |
| 12 | Relative biochemical aspects of low and high doses of methotrexate in mice. | 28 |
| 13 | Biochemical measurments during methotrexate and citrovorum infusion in mice. Abstr. | 1 |
| 14 | 4 | |
| 15 | Methotrexate Pharmacokineticsbreakdown → | 380 |
| 16 | 85 | |
| 17 | Interspecies correlation of plasma concentration history of methotrexate (NSC-740). | 153 |
| 18 | 4 | |
| 19 | 30 | |
| 20 | 4 |
About Daniel S. Zaharko
Daniel S. Zaharko is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (18 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Pharmacology (367 citations), Biomaterials (317 citations) and Oncology (552 citations). Daniel S. Zaharko has collaborated with scholars based in United States, Malaysia and Italy. Frequent co-authors include Robert L. Dedrick, Kenneth B. Bischoff, John N. Weinstein, Richard L. Magin, James Longstreth, Vincent T. Oliverio, Lyle V. Beck, Milton B. Yatvin, Robert J. Lutz and Herbert M. Pinedo. Their work appears in journals such as Science, The Journal of Immunology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.